109 filings
Page 3 of 6
8-K
qgk3v
2 Oct 20
Other Events
5:19pm
8-K
rw2bwh7utrb3w88p lk
28 Sep 20
Submission of Matters to a Vote of Security Holders
4:56pm
8-K
3fisxa1i3jov74s 3ze1
11 Aug 20
Results of Operations and Financial Condition
7:01am
8-K
tfw53ki w6a
10 Jun 20
Axovant Announces Year-End Financial Results and Expected Key Clinical Milestones in Q4 2020
6:02am
8-K
yzf2boc99lun6
29 Apr 20
Entry into a Material Definitive Agreement
5:00pm
8-K
jc2b0eew5f5rvhdg1
24 Apr 20
Other Events
7:31am
8-K
h25w9ea
20 Apr 20
Termination of a Material Definitive Agreement
5:21pm
8-K
prhce
26 Mar 20
Amendments to Articles of Incorporation or Bylaws
4:15pm
8-K
lgly9obnql hcqdkj9lh
21 Feb 20
Other Events
5:16pm
8-K
6uzu wl5s
19 Feb 20
Departure of Directors or Certain Officers
6:01am
8-K
6wllkh9jeqkyvr20ylgg
10 Feb 20
Results of Operations and Financial Condition
6:05am
8-K
d51f7sgc nan51ll9g
13 Jan 20
Regulation FD Disclosure
6:43am
8-K
1v139sk hn
3 Dec 19
Axovant Announces Amendment to Credit Facility with Hercules Capital
7:19am
8-K
xnweda nk
8 Nov 19
Departure of Directors or Certain Officers
4:53pm
8-K
7kixsw tmy6vt
8 Nov 19
Results of Operations and Financial Condition
8:03am
8-K
5i4aeqayrub3n io
23 Oct 19
Axovant Presents First Evidence of Clinical Stabilization in Tay-Sachs Disease at the European Society of Gene and Cell Therapy 27th Annual Congress
7:03am
8-K
rfutybq2
24 Sep 19
Departure of Directors or Certain Officers
5:12pm
8-K
ijx22r4
6 Sep 19
Other Events
7:30am
8-K
3mwqa5mf2
16 Aug 19
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
yzbl8sszsp7dv958
9 Aug 19
Results of Operations and Financial Condition
7:03am